Core Viewpoint - Kahn Swick & Foti, LLC is investigating the proposed merger between McCormick & Company, Incorporated and Unilever PLC's Foods business, focusing on the fairness and adequacy of the merger process for McCormick shareholders [1]. Summary by Category Merger Details - The merger agreement stipulates that upon closing, McCormick shareholders will own 35.0% of the combined company [1]. Legal Investigation - Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is assessing whether the merger process and terms are fair to McCormick shareholders [1].

Core Viewpoint - Kahn Swick & Foti, LLC is investigating the proposed sale of Apellis Pharmaceuticals, Inc. to Biogen Inc. to assess the adequacy of the price and process involved in the transaction [1]. Summary by Relevant Sections - **Proposed Transaction Details** - Apellis shareholders are set to receive $41.00 per share in cash along with a nontransferable contingent value right for two additional payments of $2.00 per share, contingent on meeting specific annual global net sales thresholds for SYFOVRE [1]. - **Investigation Purpose** - The investigation aims to determine whether the proposed consideration undervalues Apellis Pharmaceuticals and whether the process leading to this valuation was adequate [1]. - **Contact Information for Investors** - Investors who believe the transaction undervalues the company can contact Kahn Swick & Foti, LLC for further discussion regarding their legal rights [2].

Core Insights - Jaguar Mining reported its financial results for the fourth quarter and full year 2025, highlighting challenges due to a production suspension at the Satinoco facility, but indicating a controlled restart of operations [2][3]. Financial Performance - Gold production in Q4 2025 was 9,356 ounces, with 9,124 ounces sold at cash operating costs of $1,456 per ounce and all-in sustaining costs of $2,268 per ounce. The realized gold price was $4,170 per ounce [4]. - For the full year 2025, gold production totaled 40,254 ounces, with 39,453 ounces sold at cash operating costs of $1,277 per ounce and all-in sustaining costs of $1,931 per ounce. The realized gold price was $3,421 per ounce [4]. - Revenue for Q4 2025 was $38.0 million, a 10% decrease compared to Q4 2024, while full-year revenue was $135.2 million, down 15% from 2024 [5]. - The net loss for Q4 2025 was $20.5 million, translating to a loss per share of $0.24. Adjusted net loss was $3.3 million or $0.06 per share [6]. - For the full year, the net loss was $15.8 million (loss per share of $0.20), while adjusted net income was $18.5 million (earnings per share of $0.23) [8]. Operating Costs and Cash Flow - Operating costs in Q4 2025 were $13.3 million, a 25% decrease from $17.7 million in Q4 2024. For the full year, operating costs fell 31% to $50.4 million from $73.3 million in FY 2024 [9]. - Free cash flow for Q4 2025 was $0.7 million, while for the full year it was $16.6 million, with free cash flow per ounce sold at $73 and $422 respectively [11]. Strategic Outlook - The CEO emphasized the company's resilience and the successful management of the operational challenges, stating that the company is well-positioned to return to its growth strategy in 2026, projecting gold production between 50,000 to 60,000 ounces from current assets [12].

Group 1: Oil Price Movements - U.S. crude oil for May increased by 1.5% to $102.92 per barrel, with prices rising approximately 51% in March, marking West Texas Intermediate's best month since May 2020 [1] - Brent contract for June delivery also rose by 1.5% to $105.56 per barrel, with prices surging over 60% in March, representing the strongest monthly rally since 1988 [1] Group 2: Geopolitical Tensions and Supply Disruptions - Escalating attacks in the Persian Gulf and U.S. President Trump's signals regarding exiting the Iran conflict have kept markets on edge, contributing to energy supply disruptions since the war began on February 28 [2] - The war has effectively halted shipments through the Strait of Hormuz, a critical waterway that typically accounted for 20% of global oil flows before the conflict [3] Group 3: U.S. Military and Diplomatic Stance - President Trump indicated that U.S. military forces are expected to leave Iran in "two or three weeks," suggesting a declaration of victory without the need for a negotiated deal [3] - White House spokesperson announced that Trump will deliver a national address regarding Iran, indicating ongoing military hostilities and potential threats to U.S. companies in the region [4] Group 4: Iranian Response and Communications - Iranian Revolutionary Guards announced intentions to attack U.S. companies in the region, listing major corporations such as Google, Microsoft, and Apple [4] - Iranian Foreign Minister stated that while messages have been exchanged with the U.S., they do not constitute negotiations, emphasizing that communications are strictly through the Foreign Ministry [5]

Core Insights - SpaceX is preparing for a significant initial public offering (IPO) internally codenamed Project Apex, expected to value the company at $1.75 trillion, making it one of the most anticipated stock market debuts on Wall Street [6]. Group 1: Underwriting Syndicate - The IPO is being managed by a large syndicate of at least 21 banks, which is one of the largest underwriting groups assembled in recent years [6]. - Major banks serving as active bookrunners include Morgan Stanley, Goldman Sachs, JPMorgan Chase, Bank of America, and Citigroup, with an additional 16 banks participating in smaller roles [6][8]. - The size of the syndicate highlights the scale and complexity of the planned offering, reflecting a trend towards larger IPO syndicates for mega deals [2][8]. Group 2: Bank Roles and Market Context - The banks involved are expected to engage with institutional, high-net-worth, and retail investor channels across various geographic regions [5][8]. - The trend of large IPO syndicates has been observed in recent high-profile listings, such as ARM Holdings in 2023 and Alibaba Group in 2014, indicating a shift in how major offerings are structured [5][8].

Core Viewpoint - Asian equities and government bonds experienced an increase due to optimism regarding a swift resolution to the Middle East conflict, which alleviated concerns about high inflation driven by sustained elevated oil prices [1] Group 1 - Asian equities rose as investors reacted positively to the potential for a quick end to the ongoing conflict in the Middle East [1] - Government bonds in Asia also saw an uptick, reflecting a broader market sentiment of relief regarding geopolitical tensions [1] - The rise in equities and bonds indicates a market response to easing inflationary pressures that were previously exacerbated by high oil prices [1]

Group 1: Company Overview - Circle Internet Group has gained significant attention in the crypto market since its public listing in June, largely due to the hype surrounding stablecoins and their potential to transform financial markets [1] - Circle's stock has experienced high volatility, with a notable decline since reaching an all-time high of nearly $300 last summer, although it has increased by 25% in 2026 [1] Group 2: Market Potential - The stablecoin market is projected to grow significantly, with estimates suggesting it could reach $3 trillion by 2030, indicating a multitrillion-dollar opportunity for Circle [2] - Circle's USDC stablecoin currently holds approximately 25% of the stablecoin market, making it a key player alongside Tether [4] Group 3: Strategic Partnerships - Coinbase Global is a major supporter of USDC, actively working to enhance consumer demand through initiatives such as partnerships with Shopify and experimenting with AI for stablecoin payments [5] Group 4: Financial Metrics - Circle's current market capitalization stands at $22 billion, with analysts predicting it could reach $75 billion by 2030, representing a potential 225% increase [7] Group 5: Regulatory Environment - Circle's performance is closely tied to regulatory developments in Washington, D.C., with past legislation positively impacting its stock value [8] - Upcoming legislation, specifically the Clarity Act, poses potential risks as it may limit rewards on stablecoins, leading to a significant drop in Circle's stock value by 20% upon investor concerns [9][10]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of ImmunityBio, Inc. securities between January 19, 2026, and March 24, 2026, due to alleged misleading statements made by the company [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Patrick Soon-Shiong, a defendant, materially overstated the capabilities of Anktiva, leading to false and misleading statements about ImmunityBio's business and operations [5]. - Investors who purchased ImmunityBio securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must move the Court by May 26, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has been ranked highly in the industry since 2013 [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Hercules Capital, Inc. securities, alleging misleading statements and failures to disclose critical information during the Class Period from May 1, 2025, to February 27, 2026 [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Hercules Capital overstated its due diligence in deal sourcing and loan origination, as well as in portfolio valuation processes [5]. - Allegations include misclassification of portfolio investments and misrepresentation of portfolio valuations, leading to materially misleading statements about the company's business and prospects [5]. - Investors are encouraged to join the class action to seek compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by May 19, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in the field, being ranked No. 1 for securities class action settlements in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nektar Therapeutics securities between February 26, 2025, and December 15, 2025, of the May 5, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Nektar securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3]. - The lawsuit alleges that defendants made false or misleading statements regarding the REZOLVE-AA trial, which could have negatively impacted its results and misrepresented its integrity [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4].